Furthermore, the study of Fischer et al. suggests that evaluating endogenous substrates of CRBN such as MEIS2 and neo-substrates such as Ikaros and Aiolos may be considered as potential mechanisms of AML sensitivity to IMiDs (67). Here, IKZF3 is linked to acute myeloid leukemia.